Biostage (BSTG) Tops Q2 EPS by 4c

Biostage (Nasdaq: BSTG) reported Q2 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).

• Cash used in operating activities was $1.5 million in Q2 2016 compared with $2.0 million in Q2 2015.
• Cash on hand June 30, 2016 was $8.1 million, reflecting the proceeds from a $5 million private placement completed mid-May 2016.

For earnings history and earnings-related data on Biostage (BSTG) click here.

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• Stock Yards Bancorp (SYBT) Tops Q1 EPS by 7c
• Boeing (BA) Tops Q1 EPS by 50c